Back
Marker Therapeutics Quote, Financials, Valuation and Earnings
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
39
MRKR
Marker Therapeutics
Last Price:
3.64
Seasonality Move:
8.13%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Marker Therapeutics Price Quote
$3.64
-0.08 (-2.15%)
(Updated: November 13, 2024 at 5:55 PM ET)
Marker Therapeutics Key Stats
Sell
39
Marker Therapeutics (MRKR)
is a Sell
Day range:
$3.60 - $3.75
52-week range:
$2.44 - $6.16
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.42%
Volume:
11.8K
Avg. volume:
43.7K
1-year change:
36.51%
Market cap:
$33.2M
Revenue:
$0
EPS:
$-1.18
How Much Does Marker Therapeutics Make?
Data Unavailable
Is Marker Therapeutics Growing As A Company?
Data Unavailable
Marker Therapeutics Stock Price Performance
-
Did Marker Therapeutics Stock Go Up Last Month?
Marker Therapeutics share price went up by 37.27% last month -
Did MRKR's Share Price Rise Over The Last Year?
MRKR share price rose by 36.51% over the past 1 year
What Is Marker Therapeutics 52-Week High & Low?
-
What Is Marker Therapeutics’s 52-Week High Share Price?
Marker Therapeutics has traded as high as $6.16 over the past 52 weeks -
What Is Marker Therapeutics’s 52-Week Low Share Price?
Marker Therapeutics has traded as low as $2.44 over the past 52 weeks
Marker Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Marker Therapeutics?
-
How Much Debt Does Marker Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Marker Therapeutics Have?
Cash and short term investments quarterly total is $7.8M -
What Is Marker Therapeutics’s Book Value Per Share?
Book value per share is 1.09
Is Marker Therapeutics Cash Flow Positive?
-
What Is MRKR Cash Flow From Operations?
Cash flow from operations (TTM) is -$10.9M -
What Is Marker Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $578.1K -
What Is Marker Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Marker Therapeutics Return On Invested Capital
Data Unavailable
Marker Therapeutics Earnings Date & Stock Price
-
What Is Marker Therapeutics's Stock Price Today?
A single share of MRKR can be purchased today for 3.72 -
What Is Marker Therapeutics’s Stock Symbol?
Marker Therapeutics trades on the nasdaq under the ticker symbol: MRKR -
When Is Marker Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Marker Therapeutics is scheduled on November 15, 2024 -
When Is MRKR's next ex-dividend date?
Marker Therapeutics's next ex-dividend date is November 14, 2024 -
How To Buy Marker Therapeutics Stock?
You can buy Marker Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Marker Therapeutics Competitors
-
Who Are Marker Therapeutics's Competitors?
Below is a list of companies who compete with Marker Therapeutics or are related in some way:
Marker Therapeutics Dividend Yield
-
What Is MRKR Dividend Yield?
Marker Therapeutics’s dividend yield currently is 0% -
What Is Marker Therapeutics’s Payout Ratio?
Marker Therapeutics’s payout ratio is 0% -
When Did Marker Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Marker Therapeutics’s Dividend Per Share?
Marker Therapeutics pays a dividend of $0.00 per share
Marker Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 41.86% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 19.00 |
| Upside from Last Price: | 410.75% |